Trial | NCT00120237  Report issue

Title

Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan
A Placebo-Controlled Randomized Trial of Misoprostol in the Management of the Third Stage of Labor in the Home Delivery Setting in Rural Pakistan

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    1600
This community-based trial will study misoprostol for the prevention of postpartum hemorrhage in rural Pakistan. Traditional birth attendants assisting home deliveries will administer study tablets (600 mcg oral misoprostol or placebo) in the third stage of labor to women participating in the trial. Blood loss, hemoglobin levels, side effects, and other variables will be evaluated.
Study Started
Jul 31
2005
Primary Completion
Jul 31
2008
Study Completion
Jul 31
2008
Last Update
Mar 19
2009
Estimate

Drug Misoprostol

600 mcg oral misoprostol administered during third stage of labor

Criteria 

Inclusion Criteria:

Pregnant women in general good health, home delivery
Must live in one of 78 study villages

Exclusion Criteria:

Hypertension
Non-cephalic presentation
Polyhydramnios
Previous cesarean section
Suspected multiple pregnancy
Suspected still birth
Antepartum hemorrhage
Previous complication in 3rd trimester
Anemia of <8 g/dl
No Results Posted